Bespoke Extracts (BSPK) Other Operating Expenses (2011 - 2025)
Bespoke Extracts (BSPK) reported Other Operating Expenses of -$236031.0 for Q3 2025, up 32.22% on a YoY basis from -$178509.4 in Q3 2024, and up 19.85% sequentially from -$294477.0 in Q2 2025.
Bespoke Extracts (BSPK) Other Operating Expenses (2011 - 2025) Analysis & Trends
Bespoke Extracts (BSPK) has 15 years of Other Operating Expenses data on file, last reported at -$236031.0 in Q3 2025.
- For the quarter ending Q3 2025, Other Operating Expenses rose 32.22% year-over-year to -$236031.0; the trailing twelve-month figure through Sep 2025 stood at $672060.0 (up 206.15% YoY), and the FY2024 full-year result was $168202.0, down 26.38% from the prior year.
- Other Operating Expenses advanced to -$236031.0 in Q3 2025, from -$294477.0 in the prior quarter.
- In the past five years, Other Operating Expenses ranged from a high of $1.2 million in Q4 2024 to a low of -$348248.0 in Q3 2024.
- A 5-year average of $39217.8 and a median of $46883.0 in 2023 frame the typical range for Other Operating Expenses.
- Across the five-year window, Other Operating Expenses soared 5406.09% in 2024 and sank 1066.29% in 2025, its largest moves.
- Tracing BSPK's Other Operating Expenses over 5 years: stood at $2665.0 in 2021, then surged by 2424.2% to $67270.0 in 2022, then slumped by 68.46% to $21217.0 in 2023, then soared by 5406.09% to $1.2 million in 2024, then slumped by 120.2% to -$236031.0 in 2025.
- Business Quant data shows BSPK's Other Operating Expenses at -$236031.0 in Q3 2025, -$294477.0 in Q2 2025, and $34341.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Bespoke Extracts | 1.12 Mn | 1.11 Mn | 234,175.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -236,031.00 |
| Jun 30, 2025 | -294,477.00 |
| Mar 31, 2025 | 34,341.00 |
| Dec 31, 2024 | 1.17 Mn |
| Sep 30, 2024 | -348,248.00 |
| Jun 30, 2024 | 30,475.00 |
| Mar 31, 2024 | -336,544.00 |
| Dec 31, 2023 | 21,217.00 |
| Sep 30, 2023 | 46,883.00 |
| Jun 30, 2023 | 81,172.00 |
| Mar 31, 2023 | 79,204.00 |
| Dec 31, 2022 | 67,270.00 |
| Sep 30, 2022 | 65,020.00 |
| Jun 30, 2022 | 70,993.00 |
| Mar 31, 2022 | 77,355.00 |
| Nov 30, 2021 | 2,665.00 |
| Aug 31, 2021 | 11,682.00 |
| May 31, 2021 | 100,415.00 |
| Feb 28, 2021 | 103,519.00 |
| Nov 30, 2020 | 65,226.00 |